What is this ingredient?

미국 FDA 물질 등록 · UNII 88S87KL877 · 등록명 ROSIN · 혼합물

Ingredient Dictionary

ROSIN

Rosin is the residue left after distilling off the volatile oil from the oleoresin obtained from Pinus palustris and other species of Pinaceae.

How much products actually contain

No product states its amount yet.

Of the products containing it, 11 list it before the 1% line and 6 after it (usually 1% or less).

Products using this ingredient

12 of 17 confirmed · likeliest to carry enough first · See all 17

Definition

US FDA substance register · UNII 88S87KL877 · registered name ROSIN · mixture

Source: US FDA Unique Ingredient Identifier (UNII)

Rosin is the residue left after distilling off the volatile oil from the oleoresin obtained from Pinus palustris and other species of Pinaceae.

Cosmetic roles

Leaves a thin film where appliedFILM FORMINGDissolves hair to remove itDEPILATORYHolds powders togetherBINDINGAdjusts thicknessVISCOSITY CONTROLLING

Safety & regulatory references

Banned: International fragrance standard (IFRA)

Source: IFRA fragrance standards

Not classified under Korea’s toxic-substance GHS list · existing chemical substance

Source: Korea toxic substances GHS register (NIER)

Other restriction: ban substances that deplete the ozone layer

Source: EU CosIng ingredient list

More data — names, identifiers, properties, test records, literature

Official labels & definitions

JCIA labelling name ロジン: 本品は、Pinaceae （マツ属）の分泌物から精油を除いて得た固形の樹脂である。

Source: JCIA labelling names (Japan)

Names & identifiers

ROSININCI로진Korean label name (MFDS standard)COLOPHONIUMSynonymロジンJapanese labelling name

CAS No.chemical registry number: 8050-09-7
EC No.EU chemical inventory number: 232-475-7
EC No.EU chemical inventory number: 232-475-7 (I)
DTXSIDUS EPA chemical ID: DTXSID7027702

Measured properties

Melting/freezing point: 100~150 ℃
Flash point: 180~188 ℃
Upper/lower flammability or explosive limits: 0.002 %
Relative density: 1.07-1.09
Auto-ignition temperature: (&amp, gt, 390℃)

Values measured on the substance itself. The KOSHA data are a reference for writing and reviewing safety data sheets, not a specification for a commercial raw material.

Source: KOSHA safety data sheets (Korea)

What products actually use it for

What the 76 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.

Adhesion/cohesion promoter24
Binder17
Processing aids not otherwise specified8
Film former4
Intermediate3
Viscosity modifier3
Monomers2
Surfactant (surface active agent)2

11 other uses

Fuel2
Depilatory (EPA)2
Hardener1
Pigment1
Fragrance1
Emulsifier1
Flavouring and nutrient1
Dye1
Thickening agent1
Diluent1
Stabilizing agent1

Source: US EPA CompTox dashboard

Irritation and sensitisation studies

16 skin studies and 4 eye studies are on record.

Classed as moderate1

The study conclusions largely agree (100%). These tests are on the raw material itself; irritation at the amount in a finished product is a different question.

See all 20 studies

Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation)
Ambiguous
skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
Not classified
Skin Irritation · Screening
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to EU Method B.6 (Skin Sensitisation)
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation)
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation) according to EU Method B.6 (Skin Sensitisation)
Not likely to be sensitizing
skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: standard Draize method equivalent or similar to
Not likely to be sensitizing
skin sensitisation: in vivo (LLNA) · Screening · equivalent or similar to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
High Frequency of Sensitization
skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to
Skin Sens. 1
Skin Sensitization · Authoritative
Category 1
Skin Sensitization · Screening
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
Sh
Skin Sensitization · Authoritative
Category 6.5B (Category 1)
Skin Sensitization · Read Across
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to
Severe Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to
Category 2B
Eye Irritation · Screening